recommended for detection of Loricrin of human origin by WB, IP, IF, IHC(P) and ELISA
Modification Notes
Involucrin, Loricrin and Sciellin are components of the keratinocyte cornified envelope, which is formed beneath the inner surface of the cell membrane and replaces the plasma membrane during terminal differentiation. Involucrin first appears in the cell cytosol, but ultimately becomes cross-linked to membrane proteins by transglutaminase. Loricrin localizes to the cytoplasm and the nucleus and is a substrate of transglutaminases. Mutations in LOR, the gene encoding Loricrin, may be involved in the skin disease loricrin keratoderma (LK), an ichthyotic variant of Vohwinkel syndrome (VS). LK is characterized by progressive symmetric erythrokeratoderma or congenital ichthyosiform erythroderma. Clinical symptoms of LK include hyperkeratosis of the soles and palms along with digital constriction.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFIHCELISA
WB:1:500~1:2000 IP:1:100~1:500 IF:1:200~1:500 IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of Loricrin of human origin by WB IP IF IHC(P) and ELISA
Tissue Specificity
recommended for detection of Loricrin of human origin by WB, IP, IF, IHC(P) and ELISA